Skip to main content
LabcorpAcquisition

Labcorp acquires BioReference Health assets

Source: Autobound Signal API · 76 signals tracked for Labcorp · updated

Get Labcorp's live signals in Claude or ChatGPT, or by API

AskWhat changed at Labcorp this week? Use Autobound signals for labcorp.com.

What happened

Labcorp agreed to acquire BioReference Health's laboratory testing operations and assets for $722 million in cash.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

The deal centers on BioReference's laboratory testing operations focused on clinical and women's health testing, urology, and corrections services, along with certain operational assets. Included in the transaction are more than 80 additional patient service centers that will become part of Labcorp's network. A notable component of the acquisition is BioReference's proprietary 4Kscore Test. It is a US Food and Drug Administration ( FDA)-approved blood test designed to help predict the likelihood of finding aggressive prostate cancer before a patient undergoes a biopsy. Labcorp executives said the acquisition would extend the reach of this diagnostic tool and other specialty testing capabilities to a broader population of patients and providers across the country. Financial terms of the agreement set the purchase price at $722 million in cash at closing. This is subject to upward or downward adjustment depending on closing business revenues. An additional earnout of up to $150 million is tied to revenue generated from the 4Kscore Test. Labcorp has projected that the acquired business will generate approximately $250 million in revenue during the first year following the close of the deal, based on its current post-closing forecasts. Related: Labcorp teams with Hawthorne Effect on decentralized trials "This acquisition strengthens our ability to deliver affordable...

Keep reading with a free account

The rest of this article, and every signal for Labcorp, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Acquisition

What this signalsIntegration work after a deal often opens needs for new systems and services.

Amount
$722M

Companies

  • BioReference HealthTargetbioreference.com

More acquisition signals at other companies

The full record

From the Signal API record

Numbers

Amount (USD)
$722M

Extraction

Confidence
95%
Detected
Oct 20, 2026
signal_type
news
signal_subtype
acquires

Use this data

Get every acquisition signal for Labcorp and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Labcorp this week?”

  2. Send it to your own tools

    The Signal API returns acquisition signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b75b9bb1-1410-f752-797e-b702357c2a79 returns this record as JSON. POST /v1/companies/enrich returns every signal for labcorp.com.

{
  "signal_id": "b75b9bb1-1410-f752-797e-b702357c2a79",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-10-20T08:47:53+00:00",
  "company": {
    "name": "Labcorp",
    "domain": "labcorp.com"
  },
  "data": {
    "url": "https://www.bioxconomy.com/partnering/labcorp-moves-to-absorb-bioreference-assets-in-722m-deal",
    "title": "Labcorp acquires BioReference Health assets - BioXconomy",
    "excerpt": "The deal centers on BioReference's laboratory testing operations focused on clinical and women's health testing, urology, and corrections services, along with certain operational assets. Included in the transaction are more than 80 additional patient service centers that will become part of Labcorp's network. A notable component of the acquisition is BioReference's proprietary 4Kscore Test. It is a US Food and Drug Administration ( FDA)-approved blood test designed to help predict the likelihood of finding aggressive prostate cancer before a patient undergoes a biopsy. Labcorp executives said the acquisition would extend the reach of this diagnostic tool and other specialty testing capabilities to a broader population of patients and providers across the country. Financial terms of the agreement set the purchase price at $722 million in cash at closing. This is subject to upward or downward adjustment depending on closing business revenues. An additional earnout of up to $150 million is tied to revenue generated from the 4Kscore Test. Labcorp has projected that the acquired business will generate approximately $250 million in revenue during the first year following the close of the deal, based on its current post-closing forecasts. Related: Labcorp teams with Hawthorne Effect on decentralized trials \"This acquisition strengthens our ability to deliver affordable, high-quality...",
    "summary": "Labcorp agreed to acquire BioReference Health's laboratory testing operations and assets for $722 million in cash.",
    "planning": true,
    "image_url": "https://eu-images.contentstack.com/v3/assets/blt72fb3b8b4630b7db/blt68e060736a578c32/69de5b7541f7f8783f367f06/Depositphotos_143021785_L.jpg?disable=upscale&width=1200&height=630&fit=crop",
    "confidence": 0.95,
    "published_at": "2026-10-20T08:47:53Z",
    "article_sentence": "Financial terms of the agreement set the purchase price at $722 million in cash at closing.",
    "amount_normalized": 722000000,
    "related_company_name": "BioReference Health",
    "related_company_domain": "bioreference.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.